The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel

Sachin D. Patel Chayya, 67 Swastik Society, N.S. Road No.5, JVPD Scheme, Next to Joy Elegance Building, Vile Parle (West), Mumbai - 400056, Maharashtra. 4th August 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Scrip Code: 506879 Bandra (East), Mumbai- 400051 Symbol:GUJTHEM Email Id: corp.relations@bseindia.com Email Id: takeover@nse.co.in Dear Sir / Madam, Sub:- Disclosures under Regulation 10(6) – Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. In reference to the caption subject matter and aforementioned reference details, I, the undersigned is enclosing herewith the disclosure under Regulation 10(6) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ("SAST Regulations"). The acquirer had already made prior Intimation of Inter Se Transfer on 14th July 2026. You are requested to take the same on your record and oblige. Thanking you, Yours faithfully, Sachin D. Patel Acquirer Vineet Gawankar Company Secretary and Compliance Officer Gujarat Themis Biosyn Limited 69/C GIDC Industrial Estate, Vapi – 396 195, Dist. Valsad, Gujarat, India cfoassist@themismedicare.com Encl.: As above Sachin D. Patel Chayya, 67 Swastik Society, N.S. Road No.5, JVPD Scheme, Next to Joy Elegance Building, Vile Parle (West), Mumbai - 400056, Maharashtra. Disclosures under Regulation 10(6) –Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. 1. Name of the Target Company (TC) Gujarat Themis Biosyn Limited 2. Name of the acquirer(s) Sachin D. Patel 3. Name of the stock exchange where shares BSE Ltd. of the TC are listed National Stock Exchange of India Limited 4. Details of the transaction including 5,23,560 equity shares acquired rationale, if any, for the transfer/ acquisition of shares. Inter-se transfer among the Promoter and Promoter Group. 5. Relevant regulation under which the Regulation 10(1)(a)(iI) - persons named as acquirer is exempted from making open promoters in the shareholding pattern filed by offer. the target company in terms of the listing regulations 6. Whether disclosure of proposed acquisition Disclosures required Whether the was required to be made under regulation to be made under disclosures under 10 (5) and if so, regulation 10(5) – regulation 10(5) are - whether disclosure was made and whether actually made it was made within the timeline specified Yes, disclosure under under the regulations. Yes regulation 10(5) have - date of filing with the stock exchange. been mate 4 (four) working days prior to the transaction to the stock exchanges. Date of filing: 14th July 2026 7. Details of acquisition a. Name of the transferor / seller Pharmaceutical Business Group India Limited b. Date of acquisition 30th July 2026 c. Number of shares/ voting rights in 5,23,560 respect of the acquisitions from each person mentioned in 7(a) above d. Total shares proposed to be acquired / 0.48% actually acquired as a % of diluted share capital of TC e. Price at which shares are proposed to Rs. 382 be acquired / actually acquired 8. Shareholding details Pre-Transaction Post-Transaction No. of % w.r.t No. of % w.r.t shares held total shares held total share share Sachin D. Patel Chayya, 67 Swastik Society, N.S. Road No.5, JVPD Scheme, Next to Joy Elegance Building, Vile Parle (West), Mumbai - 400056, Maharashtra. capital capital of TC of TC a. Each Acquirer / Transferee (*) Sachin D. Patel 24,97,200 2.29% 30,20,760 2.77% b. Each Seller / Transferor Pharmaceutical Business Group India 5,12,40,000 47.02% 5,07,16,440 46.54% Limited Note: This disclosure is in relation to exemption for inter se transfer of shares between promoters and promoter group in compliance with Reg 10 / applicable provisions of the SEBI Takeover Regulation. Note: (*) Shareholding of each entity shall be shown separately and then collectively in a group. The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers. Sachin D. Patel Acquirer Place: Mumbai Date: 04/08/2026